What Changed
Price Move History
- Daily moves over 5%
- 76 217 sessions, November 18, 2025 to November 18, 2026
- Largest daily move
- +9900% close of December 10, 2025
- 1-year change
- +0% closing prices, November 18, 2025 to November 18, 2026
- 1-month change
- +0% closing prices, October 16, 2026 to November 18, 2026
Company Description
Herborium Group (OTC: HBRM) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $546.0K.
HBRM has gained 0.0% over the past year. The last closing price was $0.0001.
This page collects what Stock Titan holds for HBRM, including price data, latest news, and short interest trends.
Stock Performance
Herborium Group (HBRM) closed at $0.0001 on November 18, 2026. Over the past 12 months, the price has gained 0.0%.
HBRM Metrics & Rankings
Price returns through November 18, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Herborium Group has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include crypto, partnership. View all HBRM news →
SEC Filings
Short Interest History
Short interest in Herborium Group (HBRM) currently stands at 49 shares. Since November 2025, short interest has decreased by 99.9%.
Days to Cover History
Days to cover for Herborium Group (HBRM) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
HBRM Company Profile & Sector Positioning
Herborium Group (HBRM) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing HBRM often look at related companies in the same sector, including CBD of Denver Inc (CBDD), Software EFF Sltns Corp (SFWJ), Anything Techs MED Inc (EXMT), CordovaCann Corp (LVRLF), and Rafarma Pharma (RAFA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HBRM's relative position within its industry.